Epigenetic signaling axis regulates proliferation and self-renewal of neural stem/progenitor cells

June 14, 2017, Chinese Academy of Sciences
Mechanism of the EZH2-miR-203-BMI1 regulatory axis in proliferation and differentiation of NSPCs. Credit: LIU Changmei

Polycomb group (PcG) proteins comprise the polycomb complexes PRC1 and PRC2 that regulate gene expression levels through histone modification. Although PRC1 and PRC2 have important roles in cancer stem cells, their functions in neural stem/progenitor cells (NSPCs) are largely unknown.

In a recent study published in Stem Cell Reports, a team led by Drs. LIU Changmei and TENG Zhaoqian of the Chinese Academy of Sciences found a novel epigenetic signaling axis (composed of PRC1, microRNA, and PRC2) that regulates self-renewal and proliferation of NSPCs. The researchers generated an Ezh2 (a key PRC2 component) conditional knockout mouse model, and found that Ezh2 loss of function results in decreased self-renewal and proliferation ability in NSPCs.

They discovered that Ezh2 represses the expression of miR-203, which negatively regulates self-renewal and proliferation of NSPCs, but promotes their neuronal differentiation capacity. In addition, they demonstrated that Bmi1 (a PRC1 component) is a direct downstream target of miR-203, and ectopic overexpression of BMI1 can rescue the self-renewal and deficiency exhibited by miR-203 overexpression in NSPCs.

As PcG proteins and microRNAs are usually co-expressed, these findings might have significant implications for other cell types or cancer tissues.

Explore further: The paradoxical roles of well-known cancer genes are mediated by oxygen levels in breast cancer

More information: Pei-Pei Liu et al, MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells, Stem Cell Reports (2017). DOI: 10.1016/j.stemcr.2017.05.007

Related Stories

The paradoxical roles of well-known cancer genes are mediated by oxygen levels in breast cancer

January 4, 2017
Oxygen deprivation, or hypoxia, has been identified by A*STAR researchers as a key factor in switching the function of major cancer genes from tumor-promoting to tumor-suppressing in a breast cancer subtype, suggesting the ...

Controlling cell-fate decisions

September 23, 2016
Rafal Ciosk and his group at the FMI have identified an important link between the Notch signaling pathway and PRC2-mediated gene silencing. They showed that a fine balance between epigenetic silencing and signaling is crucial ...

Study pinpoints driver, potential target in aggressive pediatric leukemia subtype

February 18, 2016
A University of Colorado Cancer Center study scheduled for Feb. 18, 2016 online publication in the journal Cell Reports models Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL), discovering inactivation of the ...

Recommended for you

Bladder cancer model could pave the way for better drug efficacy studies

May 21, 2018
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients ...

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas

May 18, 2018
Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas. In their report ...

Particle shows promise to prevent the spread of triple-negative breast cancer

May 18, 2018
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.

Dilemma for cancer patients as life-saving meds are tied to vision loss

May 18, 2018
(HealthDay)—A newer type of cancer treatment may offer the chance of longer survival, but the drugs could also trigger new side effects, such as vision problems.

Polygenic scores to classify cancer risk

May 18, 2018
Polygenic risk scores could be useful to stratify the risk of several cancers among patients in medical centers, allowing for the potential discovery of new associations between genes, disease and secondary effects, according ...

A way to prevent pancreatic cancer from spreading post-surgery?

May 17, 2018
Scientists at Cold Spring Harbor Laboratory (CSHL) have solved a mystery about how pancreatic cancer spreads following surgery in patients whose tumor is successfully removed. After surgery, patients' typically experience ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.